Dimensional Fund Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,864
| Closed | -$40K | – | 3457 |
|
|
2020
Q4 | $40K | Hold |
12,864
| – | – | ﹤0.01% | 3324 |
|
|
2020
Q3 | $40K | Buy |
+12,864
| New | +$58.3K | ﹤0.01% | 3312 |
|
|
2020
Q2 | – | Sell |
-10,966
| Closed | -$57K | – | 3416 |
|
|
2020
Q1 | $57K | Buy |
+10,966
| New | +$79.4K | ﹤0.01% | 3312 |
|
|
2016
Q4 | – | Sell |
-5,737
| Closed | -$91K | – | 3315 |
|
|
2016
Q3 | $91K | Sell |
5,737
-3,241
| -36% | -$89.6K | ﹤0.01% | 3236 |
|
|
2016
Q2 | $296K | Sell |
8,978
-1,034
| -10% | -$38.9K | ﹤0.01% | 3126 |
|
|
2016
Q1 | $250K | Sell |
10,012
-1,603
| -14% | -$42.9K | ﹤0.01% | 3149 |
|
|
2015
Q4 | $578K | Sell |
11,615
-133
| -1% | -$14.8K | ﹤0.01% | 3060 |
|
|
2015
Q3 | $2.1M | Sell |
11,748
-59
| -0.5% | -$11.6K | ﹤0.01% | 2806 |
|
|
2015
Q2 | $1.69M | Sell |
11,807
-190
| -2% | -$26.4K | ﹤0.01% | 2897 |
|
|
2015
Q1 | $1.62M | Sell |
11,997
-140
| -1% | -$22.9K | ﹤0.01% | 2879 |
|
|
2014
Q4 | $2.17M | Sell |
12,137
-220
| -2% | -$39.1K | ﹤0.01% | 2820 |
|
|
2014
Q3 | $2.97M | Sell |
12,357
-98
| -0.8% | -$32.7K | ﹤0.01% | 2722 |
|
|
2014
Q2 | $5.46M | Sell |
12,455
-88
| -0.7% | -$40.6K | ﹤0.01% | 2533 |
|
|
2014
Q1 | $5.74M | Buy |
12,543
+1,250
| +11% | +$649K | ﹤0.01% | 2498 |
|
|
2013
Q4 | $5.43M | Sell |
11,293
-3
| -0% | -$1.47K | ﹤0.01% | 2523 |
|
|
2013
Q3 | $5.45M | Sell |
11,296
-16
| -0.1% | -$7.67K | ﹤0.01% | 2506 |
|
|
2013
Q2 | $5.32M | Buy |
+11,312
| New | +$5.13M | 0.01% | 2460 |
|
Other funds holding IDXG
Dimensional Fund Advisors's IDXG Position: Q1 2021 in Review
Dimensional Fund Advisors sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2021, closing a stake of 12,864 shares — an estimated $40K sold.
Dimensional Fund Advisors first reported a position in IDXG in Q2 2013 and held it in 17 quarters. The position peaked at $5.74M in Q1 2014. 3 funds tracked by Wall St. Rank hold IDXG as of Q1 2021.
- Dimensional Fund Advisors reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
- Dimensional Fund Advisors sold 12,864 Interpace Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $40K.
- Dimensional Fund Advisors first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
- Dimensional Fund Advisors's Interpace Biosciences, Inc. Common Stock position peaked at $5.74M in Q1 2014.
- 3 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2021.
Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.